832 related articles for article (PubMed ID: 22172203)
1. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I
Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203
[TBL] [Abstract][Full Text] [Related]
2. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
3. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
Schweiger C; Pietzonka C; Heverhagen J; Kissel T
Int J Pharm; 2011 Apr; 408(1-2):130-7. PubMed ID: 21315813
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
5. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-stabilized silver nanoparticles for bioanalytical applications of SERS spectroscopy.
Shkilnyy A; Soucé M; Dubois P; Warmont F; Saboungi ML; Chourpa I
Analyst; 2009 Sep; 134(9):1868-72. PubMed ID: 19684912
[TBL] [Abstract][Full Text] [Related]
7. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
8. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801
[TBL] [Abstract][Full Text] [Related]
9. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
[TBL] [Abstract][Full Text] [Related]
11. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
12. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
15. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
16. Merging high doxorubicin loading with pronounced magnetic response and bio-repellent properties in hybrid drug nanocarriers.
Bakandritsos A; Papagiannopoulos A; Anagnostou EN; Avgoustakis K; Zboril R; Pispas S; Tucek J; Ryukhtin V; Bouropoulos N; Kolokithas-Ntoukas A; Steriotis TA; Keiderling U; Winnefeld F
Small; 2012 Aug; 8(15):2381-93. PubMed ID: 22549909
[TBL] [Abstract][Full Text] [Related]
17. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
18. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents.
Kohler N; Fryxell GE; Zhang M
J Am Chem Soc; 2004 Jun; 126(23):7206-11. PubMed ID: 15186157
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI.
Sun C; Sze R; Zhang M
J Biomed Mater Res A; 2006 Sep; 78(3):550-7. PubMed ID: 16736484
[TBL] [Abstract][Full Text] [Related]
20. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
